Mads Nielsen and Robert Lauritzen met with Rikshospitalet University Hospital in Oslo for a whole day yesterday discussing real clinical use of hashtagAI to support hashtagradiology and how we could collaborate. Our hosts gave us a warm welcome and concluded that Cerebriu A/S value proposition was strong and clinically relevant for Norway.
- Documentation For Our US Patent November 27, 2019
- Cerebriu performs first live clinical test at Herlev Hospital October 25, 2019
- Cerebriu in Welfare Tech Article September 12, 2019
- Cerebriu får millioner til at spotte tumorer med en algoritme July 4, 2019
- New Patent Granted July 4, 2019